RecruitingNot ApplicableNCT07606573
The SEAS Study: Sensory Engagement and Activation During Noninvasive Stimulation
Sponsor
University of Minnesota
Enrollment
40 participants
Start Date
Jun 8, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
Early feasibility study to establish quantitative physiological markers correlated with noninvasive stimulation.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria2
- Able to provide written informed consent in English.
- Willing and able to complete study procedures (e.g., ~1-hour sessions with non-invasive recordings, ~3-hour visit).
Exclusion Criteria6
- History of neurological disorders (e.g., epilepsy, migraines) or psychiatric conditions requiring medication.
- Active implanted medical devices (e.g., pacemakers, cochlear implants) or metal in the neck/forearm that could interfere with stimulation or recordings.
- Skin conditions or open wounds at stimulation sites (cervical neck, forearm).
- Women who are pregnant or breastfeeding.
- Current use of medications affecting autonomic or cortical function (e.g., beta-blockers, sedatives).
- Inability to sit still for recordings or understand instructions (e.g., due to severe vision/hearing impairment).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEExternal electrical stimulation
Electrical stimulation
DEVICEUltrasound stimulation
USS
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07606573
Related Trials
Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep
NCT074982701 location
A Study of NHL907 in Healthy Adult Participants
NCT075809241 location
A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants
NCT076350953 locations
The Effect of taVNS and Upper GI Motility
NCT076323781 location
Exploring the Role of taVNS in Nausea Management
NCT076324561 location